The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment adcmean of primary tumor as a predictor of prognosis with cervical cancer

Keiichiro Nakamura, Satoshi Kajitani, Ikuo Joja, Tomoko Haruma, Chikako Ogawa, Tomoyuki Kusumoto, Noriko Seki, Yuji Hiramatsu

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The objective of this study was to investigate the correlation of pretreatment and posttreatment measurements as the mean apparent diffusion coefficient (ADCmean) by diffusion-weighted magnetic resonance imaging (DWI) findings with prognostic factors in patients with squamous cell carcinoma (SCC) of primary cervical cancer. The pretreatment and posttreatment ADCmean of the primary tumor were examined for their correlations with the prognosis in 69 patients with SCC of primary cervical cancer by radiotherapy (RT) with or without concurrent chemotherapy (CCRT). The median disease-free survival (DFS) and overall survival (OS) times of patients were 20.97 and 23.47 months (follow-up periods for DFS and OS: 1-72 and 1-72 months). The DFS and OS rates of patients with low pretreatment and posttreatment ADCmean of the primary tumor were also significantly worse than those of patients exhibiting high pretreatment and posttreatment ADCmean of the primary tumor (DFS; P = 0.0130 and P 

Original languageEnglish
Pages (from-to)519-525
Number of pages7
JournalCancer Medicine
Volume2
Issue number4
DOIs
Publication statusPublished - 2013

Fingerprint

Uterine Cervical Neoplasms
Disease-Free Survival
Neoplasms
Squamous Cell Carcinoma
Diffusion Magnetic Resonance Imaging
Survival
Radiotherapy
Survival Rate
Drug Therapy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment adcmean of primary tumor as a predictor of prognosis with cervical cancer. / Nakamura, Keiichiro; Kajitani, Satoshi; Joja, Ikuo; Haruma, Tomoko; Ogawa, Chikako; Kusumoto, Tomoyuki; Seki, Noriko; Hiramatsu, Yuji.

In: Cancer Medicine, Vol. 2, No. 4, 2013, p. 519-525.

Research output: Contribution to journalArticle

Nakamura, Keiichiro ; Kajitani, Satoshi ; Joja, Ikuo ; Haruma, Tomoko ; Ogawa, Chikako ; Kusumoto, Tomoyuki ; Seki, Noriko ; Hiramatsu, Yuji. / The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment adcmean of primary tumor as a predictor of prognosis with cervical cancer. In: Cancer Medicine. 2013 ; Vol. 2, No. 4. pp. 519-525.
@article{bf31d211441f48d6b7bd48e1ee36af3d,
title = "The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment adcmean of primary tumor as a predictor of prognosis with cervical cancer",
abstract = "The objective of this study was to investigate the correlation of pretreatment and posttreatment measurements as the mean apparent diffusion coefficient (ADCmean) by diffusion-weighted magnetic resonance imaging (DWI) findings with prognostic factors in patients with squamous cell carcinoma (SCC) of primary cervical cancer. The pretreatment and posttreatment ADCmean of the primary tumor were examined for their correlations with the prognosis in 69 patients with SCC of primary cervical cancer by radiotherapy (RT) with or without concurrent chemotherapy (CCRT). The median disease-free survival (DFS) and overall survival (OS) times of patients were 20.97 and 23.47 months (follow-up periods for DFS and OS: 1-72 and 1-72 months). The DFS and OS rates of patients with low pretreatment and posttreatment ADCmean of the primary tumor were also significantly worse than those of patients exhibiting high pretreatment and posttreatment ADCmean of the primary tumor (DFS; P = 0.0130 and P ",
author = "Keiichiro Nakamura and Satoshi Kajitani and Ikuo Joja and Tomoko Haruma and Chikako Ogawa and Tomoyuki Kusumoto and Noriko Seki and Yuji Hiramatsu",
year = "2013",
doi = "10.1002/cam4.100",
language = "English",
volume = "2",
pages = "519--525",
journal = "Cancer Medicine",
issn = "2045-7634",
publisher = "John Wiley and Sons Ltd",
number = "4",

}

TY - JOUR

T1 - The posttreatment mean apparent diffusion coefficient of primary tumor is superior to pretreatment adcmean of primary tumor as a predictor of prognosis with cervical cancer

AU - Nakamura, Keiichiro

AU - Kajitani, Satoshi

AU - Joja, Ikuo

AU - Haruma, Tomoko

AU - Ogawa, Chikako

AU - Kusumoto, Tomoyuki

AU - Seki, Noriko

AU - Hiramatsu, Yuji

PY - 2013

Y1 - 2013

N2 - The objective of this study was to investigate the correlation of pretreatment and posttreatment measurements as the mean apparent diffusion coefficient (ADCmean) by diffusion-weighted magnetic resonance imaging (DWI) findings with prognostic factors in patients with squamous cell carcinoma (SCC) of primary cervical cancer. The pretreatment and posttreatment ADCmean of the primary tumor were examined for their correlations with the prognosis in 69 patients with SCC of primary cervical cancer by radiotherapy (RT) with or without concurrent chemotherapy (CCRT). The median disease-free survival (DFS) and overall survival (OS) times of patients were 20.97 and 23.47 months (follow-up periods for DFS and OS: 1-72 and 1-72 months). The DFS and OS rates of patients with low pretreatment and posttreatment ADCmean of the primary tumor were also significantly worse than those of patients exhibiting high pretreatment and posttreatment ADCmean of the primary tumor (DFS; P = 0.0130 and P 

AB - The objective of this study was to investigate the correlation of pretreatment and posttreatment measurements as the mean apparent diffusion coefficient (ADCmean) by diffusion-weighted magnetic resonance imaging (DWI) findings with prognostic factors in patients with squamous cell carcinoma (SCC) of primary cervical cancer. The pretreatment and posttreatment ADCmean of the primary tumor were examined for their correlations with the prognosis in 69 patients with SCC of primary cervical cancer by radiotherapy (RT) with or without concurrent chemotherapy (CCRT). The median disease-free survival (DFS) and overall survival (OS) times of patients were 20.97 and 23.47 months (follow-up periods for DFS and OS: 1-72 and 1-72 months). The DFS and OS rates of patients with low pretreatment and posttreatment ADCmean of the primary tumor were also significantly worse than those of patients exhibiting high pretreatment and posttreatment ADCmean of the primary tumor (DFS; P = 0.0130 and P 

UR - http://www.scopus.com/inward/record.url?scp=84902085524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902085524&partnerID=8YFLogxK

U2 - 10.1002/cam4.100

DO - 10.1002/cam4.100

M3 - Article

VL - 2

SP - 519

EP - 525

JO - Cancer Medicine

JF - Cancer Medicine

SN - 2045-7634

IS - 4

ER -